tiprankstipranks
Elanco Animal Health (ELAN)
NYSE:ELAN
US Market
ELAN
Elanco Animal Health
RESEARCH TOOLSreports
Want to see ELAN full AI Analyst Report?

Elanco Animal Health (ELAN) Stock Forecast & Price Target

483 Followers
See the Price Targets and Ratings of:

ELAN Analyst Ratings

Strong Buy
11Ratings
Strong Buy
9 Buy
2 Hold
0 Sell
Based on 11 analysts giving stock ratings to
Elanco
Animal Health
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

ELAN Stock 12 Month Forecast

Average Price Target

$30.14
▲(18.63% Upside)
Based on 11 Wall Street analysts offering 12 month price targets for Elanco Animal Health in the last 3 months. The average price target is $30.14 with a high forecast of $32.00 and a low forecast of $26.00. The average price target represents a 18.63% change from the last price of $25.41.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"12":"$12","33":"$33","17.25":"$17.25","22.5":"$22.5","27.75":"$27.8"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":32,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$32.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":30.142857142857142,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$30.14</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":26,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$26.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[12,17.25,22.5,27.75,33],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Nov<br/>2025","6":"Feb<br/>2026","9":"May<br/>2026","12":"Aug<br/>2026","25":"Aug<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,26.37,26.803076923076922,27.236153846153847,27.66923076923077,28.102307692307694,28.535384615384615,28.96846153846154,29.40153846153846,29.834615384615386,30.267692307692307,30.700769230769232,31.133846153846154,31.566923076923075,{"y":32,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,26.37,26.66021978021978,26.950439560439563,27.24065934065934,27.53087912087912,27.821098901098903,28.111318681318682,28.40153846153846,28.691758241758244,28.981978021978023,29.2721978021978,29.56241758241758,29.852637362637363,{"y":30.142857142857142,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,26.37,26.341538461538462,26.313076923076924,26.284615384615385,26.256153846153847,26.22769230769231,26.19923076923077,26.17076923076923,26.142307692307693,26.113846153846154,26.085384615384616,26.056923076923077,26.02846153846154,{"y":26,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":13.79,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":17.85,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":20.8,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":22.15,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":22.62,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 22,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":22.63,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 22,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":24.75,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 24,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":26.09,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":23.12,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":22.51,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":23.67,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":24.09,"date":1782864000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":26.37,"date":1785542400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target$32.00Average Price Target$30.14Lowest Price Target$26.00
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Stifel Nicolaus Analyst forecast on ELAN
Jonathan Block
Stifel Nicolaus
Stifel Nicolaus
―
Hold
―
Reiterated
07/31/26
Analysts Offer Insights on Healthcare Companies: Elanco Animal Health (NYSE: ELAN), Biogen (NASDAQ: BIIB) and Doximity (NYSE: DOCS)
Morgan Stanley Analyst forecast on ELAN
Erin Wright
Morgan Stanley
Morgan Stanley
$23→$26
Hold
2.32%
Upside
Assigned
07/22/26
Elanco price target raised to $26 from $23 at Morgan StanleyElanco price target raised to $26 from $23 at Morgan Stanley
Piper Sandler Analyst forecast on ELAN
David Westenberg
Piper Sandler
Piper Sandler
$30
Buy
18.06%
Upside
Reiterated
06/29/26
Analysts Offer Insights on Healthcare Companies: ACADIA Pharmaceuticals (NASDAQ: ACAD), Elanco Animal Health (NYSE: ELAN) and Bristol-Myers Squibb (NYSE: BMY)
Argus Research Analyst forecast on ELAN
Jasper Hellweg
Argus Research
Argus Research
―
Buy
―
Reiterated
06/23/26
Wall Street Analysts Are Bullish on Top Healthcare Picks
TD Cowen Analyst forecast on ELAN
Steve Scala
TD Cowen
TD Cowen
$31→$32
Buy
25.93%
Upside
Assigned
06/18/26
Elanco Upgraded to Buy on Blockbuster Product Cycle, Robust Pipeline, and Higher Price Target Outlook
Barclays Analyst forecast on ELAN
Glen Santangelo
Barclays
Barclays
$30
Buy
18.06%
Upside
Reiterated
06/11/26
Barclays Reaffirms Their Buy Rating on Elanco Animal Health (ELAN)
Bank of America Securities Analyst forecast on ELAN
Michael Ryskin
Bank of America Securities
Bank of America Securities
$32
Buy
25.93%
Upside
Reiterated
06/05/26
Analysts Offer Insights on Healthcare Companies: Elanco Animal Health (NYSE: ELAN), Pharma Mar SA (Other OTC: PHMMF) and Sotera Health (NASDAQ: SHC)
William Blair Analyst forecast on ELAN
Brandon Vazquez
William Blair
William Blair
―
Buy
―
Reiterated
06/03/26
Analysts Offer Insights on Healthcare Companies: Elanco Animal Health (NYSE: ELAN) and Kazia Therapeutics (NASDAQ: KZIA)
Evercore ISI Analyst forecast on ELAN
Umer Raffat
Evercore ISI
Evercore ISI
―
Buy
―
Reiterated
05/11/26
Analysts Offer Insights on Healthcare Companies: Definitive Healthcare Corp (NASDAQ: DH), Elanco Animal Health (NYSE: ELAN) and Align Tech (NASDAQ: ALGN)
J.P. Morgan Analyst forecast on ELAN
Chris Schott
J.P. Morgan
J.P. Morgan
$28→$30
Buy
18.06%
Upside
Assigned
05/07/26
Elanco price target raised to $30 from $28 at JPMorganElanco price target raised to $30 from $28 at JPMorgan
Citi Analyst forecast on ELAN
Daniel Grosslight
Citi
Citi
$30→$31
Buy
22.00%
Upside
Reiterated
05/07/26
Elanco price target raised to $31 from $30 at CitiElanco price target raised to $31 from $30 at Citi
UBS Analyst forecast on ELAN
Andrea Alfonso
UBS
UBS
$31
Buy
22.00%
Upside
Reiterated
03/10/26
Analysts Are Bullish on These Healthcare Stocks: Elanco Animal Health (ELAN), Eli Lilly & Co (LLY)
Jefferies Analyst forecast on ELAN
Unknown Analyst
Jefferies
Not Ranked
Jefferies
$30
Buy
18.06%
Upside
Reiterated
02/25/26
Jefferies Reaffirms Their Buy Rating on Elanco Animal Health (ELAN)
KeyBanc Analyst forecast on ELAN
Scott Schoenhaus
KeyBanc
KeyBanc
$27→$29
Buy
14.13%
Upside
Reiterated
02/25/26
KeyBanc Sticks to Its Buy Rating for Elanco Animal Health (ELAN)
Leerink Partners Analyst forecast on ELAN
Daniel Clark
Leerink Partners
Leerink Partners
$30
Buy
18.06%
Upside
Reiterated
02/24/26
Analysts Offer Insights on Healthcare Companies: Elanco Animal Health (NYSE: ELAN) and Henry Schein (NASDAQ: HSIC)
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Stifel Nicolaus Analyst forecast on ELAN
Jonathan Block
Stifel Nicolaus
Stifel Nicolaus
―
Hold
―
Reiterated
07/31/26
Analysts Offer Insights on Healthcare Companies: Elanco Animal Health (NYSE: ELAN), Biogen (NASDAQ: BIIB) and Doximity (NYSE: DOCS)
Morgan Stanley Analyst forecast on ELAN
Erin Wright
Morgan Stanley
Morgan Stanley
$23→$26
Hold
2.32%
Upside
Assigned
07/22/26
Elanco price target raised to $26 from $23 at Morgan StanleyElanco price target raised to $26 from $23 at Morgan Stanley
Piper Sandler Analyst forecast on ELAN
David Westenberg
Piper Sandler
Piper Sandler
$30
Buy
18.06%
Upside
Reiterated
06/29/26
Analysts Offer Insights on Healthcare Companies: ACADIA Pharmaceuticals (NASDAQ: ACAD), Elanco Animal Health (NYSE: ELAN) and Bristol-Myers Squibb (NYSE: BMY)
Argus Research Analyst forecast on ELAN
Jasper Hellweg
Argus Research
Argus Research
―
Buy
―
Reiterated
06/23/26
Wall Street Analysts Are Bullish on Top Healthcare Picks
TD Cowen Analyst forecast on ELAN
Steve Scala
TD Cowen
TD Cowen
$31→$32
Buy
25.93%
Upside
Assigned
06/18/26
Elanco Upgraded to Buy on Blockbuster Product Cycle, Robust Pipeline, and Higher Price Target Outlook
Barclays Analyst forecast on ELAN
Glen Santangelo
Barclays
Barclays
$30
Buy
18.06%
Upside
Reiterated
06/11/26
Barclays Reaffirms Their Buy Rating on Elanco Animal Health (ELAN)
Bank of America Securities Analyst forecast on ELAN
Michael Ryskin
Bank of America Securities
Bank of America Securities
$32
Buy
25.93%
Upside
Reiterated
06/05/26
Analysts Offer Insights on Healthcare Companies: Elanco Animal Health (NYSE: ELAN), Pharma Mar SA (Other OTC: PHMMF) and Sotera Health (NASDAQ: SHC)
William Blair Analyst forecast on ELAN
Brandon Vazquez
William Blair
William Blair
―
Buy
―
Reiterated
06/03/26
Analysts Offer Insights on Healthcare Companies: Elanco Animal Health (NYSE: ELAN) and Kazia Therapeutics (NASDAQ: KZIA)
Evercore ISI Analyst forecast on ELAN
Umer Raffat
Evercore ISI
Evercore ISI
―
Buy
―
Reiterated
05/11/26
Analysts Offer Insights on Healthcare Companies: Definitive Healthcare Corp (NASDAQ: DH), Elanco Animal Health (NYSE: ELAN) and Align Tech (NASDAQ: ALGN)
J.P. Morgan Analyst forecast on ELAN
Chris Schott
J.P. Morgan
J.P. Morgan
$28→$30
Buy
18.06%
Upside
Assigned
05/07/26
Elanco price target raised to $30 from $28 at JPMorganElanco price target raised to $30 from $28 at JPMorgan
Citi Analyst forecast on ELAN
Daniel Grosslight
Citi
Citi
$30→$31
Buy
22.00%
Upside
Reiterated
05/07/26
Elanco price target raised to $31 from $30 at CitiElanco price target raised to $31 from $30 at Citi
UBS Analyst forecast on ELAN
Andrea Alfonso
UBS
UBS
$31
Buy
22.00%
Upside
Reiterated
03/10/26
Analysts Are Bullish on These Healthcare Stocks: Elanco Animal Health (ELAN), Eli Lilly & Co (LLY)
Jefferies Analyst forecast on ELAN
Unknown Analyst
Jefferies
Not Ranked
Jefferies
$30
Buy
18.06%
Upside
Reiterated
02/25/26
Jefferies Reaffirms Their Buy Rating on Elanco Animal Health (ELAN)
KeyBanc Analyst forecast on ELAN
Scott Schoenhaus
KeyBanc
KeyBanc
$27→$29
Buy
14.13%
Upside
Reiterated
02/25/26
KeyBanc Sticks to Its Buy Rating for Elanco Animal Health (ELAN)
Leerink Partners Analyst forecast on ELAN
Daniel Clark
Leerink Partners
Leerink Partners
$30
Buy
18.06%
Upside
Reiterated
02/24/26
Analysts Offer Insights on Healthcare Companies: Elanco Animal Health (NYSE: ELAN) and Henry Schein (NASDAQ: HSIC)
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
AVBPArriVent BioPharma, Inc.
BTSGBrightSpring Health Services, Inc.
MLYSMineralys Therapeutics, Inc.
AMLXAmylyx Pharmaceuticals Inc
ZURAZura Bio
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Elanco Animal Health

3 Months
Steve ScalaTD Cowen
Success Rate
11/15 ratings generated profit
73%
Average Return
+13.78%
Copying Steve Scala's trades and holding each position for 3 Months would result in 73.33% of your transactions generating a profit, with an average return of +13.78% per trade.
1 Year
Andrea AlfonsoUBS
Success Rate
9/9 ratings generated profit
100%
Average Return
+42.69%
Copying Andrea Alfonso's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +42.69% per trade.
2 Years
Andrea AlfonsoUBS
Success Rate
9/9 ratings generated profit
100%
Average Return
+49.40%
Copying Andrea Alfonso's trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +49.40% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

ELAN Analyst Recommendation Trends

Rating
Apr 26
May 26
Jun 26
Jul 26
Aug 26
Strong Buy
0
0
0
0
0
Buy
16
13
16
12
6
Hold
1
1
2
4
3
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
17
14
18
16
9
In the current month, ELAN has received 6 Buy Ratings, 3 Hold Ratings, and 0 Sell Ratings. ELAN average Analyst price target in the past 3 months is 30.14.
Each month's total comprises the sum of three months' worth of ratings.

ELAN Financial Forecast

ELAN Earnings Forecast

Next quarter’s earnings estimate for ELAN is $0.27 with a range of $0.26 to $0.29. The previous quarter’s EPS was $0.40. ELAN beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 54.29% of the time in the same period. In the last calendar year ELAN has Performed in-line its overall industry.
Next quarter’s earnings estimate for ELAN is $0.27 with a range of $0.26 to $0.29. The previous quarter’s EPS was $0.40. ELAN beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 54.29% of the time in the same period. In the last calendar year ELAN has Performed in-line its overall industry.

ELAN Sales Forecast

Next quarter’s sales forecast for ELAN is $1.31B with a range of $1.29B to $1.32B. The previous quarter’s sales results were $1.37B. ELAN beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 51.27% of the time in the same period. In the last calendar year ELAN has Performed in-line its overall industry.
Next quarter’s sales forecast for ELAN is $1.31B with a range of $1.29B to $1.32B. The previous quarter’s sales results were $1.37B. ELAN beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 51.27% of the time in the same period. In the last calendar year ELAN has Performed in-line its overall industry.

ELAN Stock Forecast FAQ

What is ELAN’s average 12-month price target, according to analysts?
Based on analyst ratings, Elanco Animal Health’s 12-month average price target is 30.14.
    What is ELAN’s upside potential, based on the analysts’ average price target?
    Elanco Animal Health has 18.63% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is ELAN a Buy, Sell or Hold?
          Elanco Animal Health has a consensus rating of Strong Buy which is based on 9 buy ratings, 2 hold ratings and 0 sell ratings.
            What is Elanco Animal Health’s price target?
            The average price target for Elanco Animal Health is 30.14. This is based on 11 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst price target is $32.00 ,the lowest forecast is $26.00. The average price target represents 18.63% Increase from the current price of $25.41.
              What do analysts say about Elanco Animal Health?
              Elanco Animal Health’s analyst rating consensus is a Strong Buy. This is based on the ratings of 11 Wall Streets Analysts.
                How can I buy shares of ELAN?
                Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.